Xencor Inc (XNCR.OQ)
XNCR.OQ on NASDAQ Stock Exchange Global Market
37.52USD
10 Dec 2018
37.52USD
10 Dec 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$37.52
$37.52
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
109,159
109,159
52-wk High
$48.31
$48.31
52-wk Low
$19.93
$19.93
About
Xencor, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. It has developed two clinical-stage product candidates, using its Immune Inhibitor Fc platform: XmAb5871, which is in two Phase II trials... (more)
Overall
| Beta: | 2.15 |
| Market Cap(Mil.): | $1,163.30 |
| Shares Outstanding(Mil.): | 46.93 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| XNCR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 92.25 | 33.63 |
| EPS (TTM): | -0.87 | -- | -- |
| ROI: | -14.67 | 0.28 | 15.02 |
| ROE: | -15.16 | 0.94 | 16.60 |
Estimates